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Abstract 
Background: It is well known that tobacco smoke causes cellular proliferation and chronic obstructive 
pulmonary disease (COPD), but changes in buccal mucosa cells in smokers and COPD patients remains 
unknown.  
Aims: The aim of this study is twofold: (i) to assess the effect of smoking on cellular proliferative activity of 
buccal mucosa in healthy smokers and in smoking COPD patients (ii) to detect early cellular proliferative 
activity in buccal mucosa. Our hypothesis is that tobacco smoking induces changes in buccal mucosa cells that 
we can detect using AgNOR analysis.  
Methods:879 male subjects; non-smokers (controls), smokers and COPD patients were studied. Cytogenic 
damage was defined using the argyrophilic nucleolar organiser regions (AgNOR). Buccal mucosa cells were 
obtained from swabs and brushing. The UHVSLUDWRU\V\PSWRPVZHUHDVVHVVHGE\6W*HRUJH¶VTXHVWLRQQDLUH and 
lung function tests were measured by Vitalograph spirometer. Statistica l analysis using ANOVA and 
discriminant analysis (classification) was used to determine differences between the three groups, regression 
models were built on the lung function data. 
Results:The AgNOR count, nuclear area, nuclear volume, and percentage of cells with 5 or more AgNORs, 
were significantly higher in smokers than non±smokers (5.20 vs 3.27, 74.66 vs 55.65, 462.67 vs 304.01, 73.93% 
vs 14.75%, respectively). For COPD patients, the values were 6.77, 110.42, 813.26, 96.97%, respectively. 
Respiratory symptoms were higher in smokers and COPD patients than non-smokers. There was significant 
UHODWLRQVKLS EHWZHHQ UHVSLUDWRU\ V\PSWRPV DQG $J125V FRXQW 3  7KHUH ZDV SRVLWLYH DVVRFLDWLRQ
between cigarette smoking and enhanced cellular activity in oral mucosa. Pack years of smoking is significantly 
associated with cellular abnormality in smokers and COPD patients.  
Conclusions: Strong correlations were found between AgNORs parameters and respir atory symptoms, 
pulmonary function tests and pack years.  
Keywords: COPD, buccal mucosa, AgNOR staining, discriminant analysis. 
 
I. INTRODUCTION 
Smoking induces changes in the nucleoprotein of buccal mucosa cells which can be detected by a 
method of silver staining the argyrophilic nucleolar organiser regions (AgNOR)(Kadivar, and Attar, 2008). The 
125¶V DUH LGHQWLILHG DVEODFNGRWV WKDW DSSHDU WKURXJKRXW WKHQXFOHRODU DUHD and can be used as histological 
biomarker in smokers to predict who is at risk of developing chronic obstructive pulmonary disease (COPD). 
Our primary aim was to assess the relationship between smoking and cellular proliferative activity of buccal 
mucosa in smokers and heavy smokers who are at risk of developing COPD and in COPD patients using 
AgNORs as a biomarker (Munteanu and Didilescu, 2007). AgNOR staining technique is a simple, non-invasive, 
painless, inexpensive accurate method and valuable marker in cells (Bukhari, et al., 2007). In addition, it has 
been used to avoid the errors which are produced during the diagnosis of malignant and benign cells 
(Remmerbach, et al., 2003). It is not a complex method and it can be used as a monitor to follow up all changes 
in the oral cavity (Chattopadhyay, and Ray, 2008). 
The secondary aim was to compare AgNORs parameters among smokers, nonsmokers and COPD patients and 
to establish prediction equations for the prediction of AgNORs using packs year, lung function tests and 
respiratory symptoms. 
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II. METHODS 
A total of 879 volunteers participated in this study. These were generally white collar workers. The COPD 
patients were selected from Quefia Chest Hospital, Benghazi, Libya. All participants were from Benghazi city 
and their demographics were similar. Socioeconomic status was similar (Omar et al., 2010).  
Exclusion criteria were: hypertension, diabetes, liver disease, hypercholesterolemia, drug and alcoholic 
addiction and oral cancer. Subjects who consumed alcohol were also excluded. The inclusion criteria were age 
greater than 30 years, no clinically visible oral lesions and no history of benign or malignant neoplasias. 
Lung function testing (FVC, FEV1, PEFR and the ratio FEV1/ FVC %) was performed by a Vitalograph 
spirometer. The statistical package SPSS was used to obtain the regression equations and linear regression was 
used with FEV1, FVC, FEV1/FVC and PEFR with height (meter) and age as independent factors (Hardie, et al., 
2002). Currently, there are no spirometric reference values for adults in Libya. This justified our approach which 
consisted in establishing reference values from the healthy sample of the population of Benghazi. The obtained 
predictive equations allowed us to calculate percentage from spirometric variables measured in smoker and in 
COPD patients. 
The following procedure was used for AgNOR staining (Ploton et al., 1986): Volunteers rinsed their mouth with 
distilled water, samples were collected from human oral mucosa by cytobrush (scraping their cheeks). Air±dried 
smears from 5 to 10 min were taken at room temperature. The slides were then fixed in Carnoy's solution (1:3 
(v/v) acetic acid: ethanol) for 5 minutes in a refrigerator at 4ºC. The slides were rehydrated progressively in 
alcohol (100%, 90%, and 70%). Followed  by rinsing in distilled water (two changes). The staining process used 
AgNOR (1x2% (w/v) gelatin in 1 % (v/v) formic acid: 2x5 % (w/v) AgNOR). The slides were placed in an oven 
at 70ºC for 10 minutes and then rinsed in distilled water. A 5% (w/v) thiosulphate solution was used to wash out 
non-specific deposits and to prevent sensitivity of the slides to light). Finally, the slides rinsed again in distilled 
water and inspected with a microscope to count and examine the black dots¶ shape and size. 
 
 
 
 
Figure 1. Oral mucosal cell in smokers including AgNOR count, AgNOR area and nuclear area 
(magnification, 100). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2, Oral mucosal cell in non-smokers including the AgNOR counts, AgNOR area and nuclear area 
(magnification, 100). 
 
Figure 1 shows that oral mucosal cell has large AgNORs dots, more AgNOR counts and large nuclear area 
compared with non-smokers. Figure 2 shows AgNOR count, diameter of AgNOR and the nuclear area were the 
lowest in non-smokers compared with other two groups.  
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Overlapped, single and cluster black dots were counted as one structure Crocker, and Murray, (2003). Nuclear 
DUHD QXFOHXV VSKHULFDO LQ VKDSH   ʌU DQG QXFOHXV RYDO LQ VKDSH  ʌDE DQG QXFOHDU YROXPH QXFOHXV
VSKHULFDOLQVKDSH »ʌUDQGQXFOHXVRYDO LQVKDSH »ʌDEZHUHPHDVXUHG,PDJHVZHUH
captured from the slides by light microscope with colour camera. Two images were taken for each participant. 
The data was used to build a linear discriminant model (Fens et al 2009). 
III. RESULTS 
Table 1 shows, there were no significant differences in age (P= 0.710) and height (P=0.999) between 
smokers and non-smokers group. Age was higher in COPD patients than smoker and non-smokers. Weight was 
higher in non-smokers than smokers (87.30kg vs 83.87kg) and it was the lowest in COPD patients (68.35kg) 
compared with these two groups. However, there was no significant difference in height between smokers and 
non-smokers groups. Height was higher in smokers and non-smokers than COPD patients. Body mass index 
(BMI) was higher in non-smokers than smokers (28.57 vs 27.42) and it was the lowest in patients group (24.74). 
Table 1 Physical Measurements of the participants (mean ± S.D) 
Variables 
 
Non- smokers 
(n= 404) 
Smokers 
(n= 403) 
Patients 
(n= 72) 
Age (yr) 40.95 (7.33)*** 40.48 (8.68) 63.15 (11.79) 
Height (cm) 174.82 (6.49)*** 174.80 (7.02) 165.88 (7.14) 
Weight (kg) 87.30 (15.23)*** 83.87 (17.26) 68.35 (17.05) 
BMI 28.57 (4.77)*** 27.42 (5.23) 24.74 (5.65) 
 3 
 
Table 2 AgNOR parameters (mean (±S.D)) 
Variables Non-smokers (n= 404) Smokers (n= 403) Patients        (n=72) 
No. of AgNOR per 
nucleus (AgNOR 
count) 
 
3.27 (0.35)*** 
 
5.20 (0.41) 
 
6.77 (0.58) 
Nuclear area (um3) 55.65 (7.62)*** 74.66 (8.70) 110.42 (7.04) 
Nuclear volume (um3) 304.01 (67.70)*** 462.67 (69.76) 813.26(81.92) 
$J125 14.75 (10.14)*** 73.93 (11.98) 96.97 (4.10) 
AgNOR area 1.25 (0.29)*** 2.46 (0.51) 3.82 (0.56) 
AgNOR volume 0.67 (0.20)*** 1.43 (0.39) 2.30 (0.43) 
Proportion of nuclear 
area occupied by 
AgNOR % 
 
2.25 (0.51)*** 
 
3.28 (0.61) 
 
3.47 (0.51) 
Proportion of nuclear 
volume occupied by 
AgNOR% 
 
0.23 (0.07)*** 
 
0.31 (0.11) 
 
0.29 (0.59) 
3 
 
 
Table 3. Classification accuracy percentages for discrimination analysis using individual AgNOR 
variables and all AgNOR variables combined 
Analysis Non-smoker(%) Smoker(%) COPD patient(%) Overall%(%) 
1. AgNOR area 97.8 80.4 91.7 89.3 
2. AgNOR volume 96.5 75.4 84.7 85.9 
3. AgNOR count 99.3 96.0 93.1 97.3 
4. Combined (1-3) 99.0 93.8 98.6 98.6 
 
 A linear regression model was built to predict the heavy smokers who are at risk of developing COPD 
and give an indication of changes observed in the oral mucosal cells. In this study, the equation was designed to 
help us to estimate these changes, depending on the pack years and FEV1 (% predict). These variables allow us 
to apply this equation to identify smokers who at risk of developing COPD depending on the results from actual 
AgNOR slide and the predicted results from the equation. This equation was tested on the subjects and the 
results were compared with the outcome from the AgNOR slides.  In this study, all AgNOR parameters such as 
nuclear area and nuclear volume have been used to construct the best equation which can be used to predict the 
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smokers at risk of development COPD. For this reason, several models using different variables were 
constructed.  
 
FVC (forced vital capacity), FEV1 (forced expiratory volume in the first second), FEV1/FVC Ratio (forced 
expiratory ratio), and PEFR (peak expiratory flow rate), SaO2 (percentage saturation of haemoglobin with R[\JHQ$J125SHUFHQWDJHRIFHOOVZLWKRUPRUH$J125SHUQXFOHXV 
In the non-smokers group (control group), FVC, FEV1, PEFR and FEV1/ FVC respectively were 
within normal values    DQG  $J125 FRXQW $J125   $J125 DUHD $J125
volume, proportion of nuclear area occupied by AgNOR% and proportion of nuclear volume occupied by 
AgNOR% were low in this group compared with smokers and COPD patients. In the smokers group, FVC, 
FEV1, FEV1/ FVC and PEFR respectively were lower than normal (4.34, 3.28, 75.52 and 407.91) and AgNOR 
count was higher in the oral mucosal cells in smokers compared with non-smokers (5.20 vs 3.27). Nuclear area 
 YV   QXFOHDU YROXPH  YV  $J125    YV $J125 area (2.46 vs 
1.25), AgNOR volume (1.43 vs 0.67), proportion of nuclear area occupied by AgNOR percentage (3.28 vs 2.25) 
and proportion of nuclear volume occupied by AgNOR percentage (0.31 vs 0.23) were higher in this group 
compared with non-smokers group.  In COPD patients, FVC, FEV1, FEV1/ FVC and PEFR respectively were 
the lowest (1.76, 0.96, 52.64 and 144.30) compared with normal smokers and non-smokers respectively. In 
addition, Saturation of oxygen was also the lowest in this group (92.28) and AgNOR FRXQW$J125
(96.97), nuclear area (110.42), nuclear volume (813.26) and proportion of nuclear area occupied by AgNOR% 
also were the highest values (3.47) compared with others groups. 
Figure 4 provides a box and whiskers plot of the data showing the contrasts between the three groups.  
The discriminant analysis model was built using cross-validation in order to correctly classify (predict) the test 
cases into one of three categories (smoker, non-smoker or COPD patient). Table three shows the results, each 
classifier is shown with the internal breakdown for each of the three classes and the overall accuracy. 
 
 
 
 
 
 
 
 
 
 
Figure 3 Showing discrimination between smokers, non-smokers and COPD patients 
 
The most accurate cross-validated model used all three AgNOR variables for a combined accuracy of 98.6%. 
Figure 3 shows the discriminant functions which clearly reveals the segregated natured of the three classes. 
 
 
 
 
 
 
 
 
Figure 4, Boxplot of the distribution of AgNOR counts in smokers, non-smokers and COPD patients. 
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IV. DISCUSSION 
Main Findings 
The AgNOR staining technique has demonstrated that there is a strong relationship between silver 
nitrate and the proliferative cellular activity which appears as black dots in oral mucosal cells (cheeks). Increase 
of AgNOR count in the oral mucosal cells indicates an increase in the proliferative cellular activity through the 
formation of protein, to repair the damage resulted from the effect of tobacco smoking. An increase in the 
proliferative activity leads to a strong chance of mutation in the mitosis cycle which finally could cause 
development of malignancy cells in the oral mucosa. Furthermore, the technique is simple, painless, efficient 
and inexpensive compared to immunohistochemistry and molecular biology techniques (De Sousa et al., 2009). 
 
Strengths and Limitations 
This is the first study looking at the association between histological changes in the buccal mucosa 
related to environmental exposure and heavy smoking, respiratory symptoms and decline in pulmonary function 
in order to identify those at risk of developing COPD.  COPD is not widespread in Benghazi Libya and this has 
been the major limiting factor during this study. In order to give a realistic indication of the situation, it is 
important to monitor patients for at least one month, especially when the symptoms initially appear. However, 
the limited number of patients did not allow direct comparison between COPD patients, smokers and non-
smokers. In the future, it would be beneficial to use a larger number of patients, although this might require a 
much longer period of investigation, as only 200 patients (in Benghazi) are registered as suffering from COPD, 
but they are not regularly monitored.  Some of these patients go to hospital only when they present severe 
symptoms. 
 
Interpretation of findings in relation to previously published work 
A study by Cancado, et al., (2004) showed that there is relationship between AgNOR count and the 
number of cigarette smoked per day. An increase in AgNOR counts in the oral mucosal cells in smokers who 
smoke more than 20 cigarettes per day (Ray, et al., 2003).The work of Usta, et al., (2008) discovered that the 
average AgNOR count in non-smokers was 3.47 ± 0.30 and in smokers was 4.20 ± 0.40. In our study, the mean 
of AgNOR count per nucleus in smokers was 5.20 (±0.41), in non-smokers was 3.27 (±0.35) and in COPD 
patients 6.77 (±0.58).  
 
Implications for future research, policy and practice 
Future work will investigate the effect of cigarette smoking on oral mucosal cells and the airway epithelial cells 
of smokers. Comparison of this effect and investigating the relationship between them is needed as well as 
investigating different severity groups of COPD patients. Comparisons will be made between smokers and 
COPD patients with, emphasis on AgNOR counts in the oral mucosal cells and the neutrophils count in sputum. 
We suggest that AgNOR staining can be used as a tool in cytology and histopathology laboratories to follow, 
estimate and diagnose COPD disease and other diseases such as oral carcinoma that result from the changes in 
oral epithelial cells.  Furthermore, the method can be used to evaluate these changes before they appear in oral 
mucosa. 
 
V. CONCLUSIONS 
We have analysed the relationship between cigarette smoking and cellular proliferative activity of 
buccal mucosa in smokers and in chronic obstructive pulmonary disease (COPD) patients. The study has also 
been able to predict smokers who are at risk of developing COPD and to detect early cellular proliferative 
activity in buccal mucosa.  The variation in AgNOR counts in this project reflects the rate of the proliferative 
activity and the degree of cytotoxic damage in the oral mucosal cells which results from exposure to chronic 
tobacco smoking. Moreover, it leads to a decline in the lung function which results from the destruction of the 
epithelial cells which line the respiratory airways and an increase in the number of goblet cells (increase mucus 
secretion) which stimulate the production of coughing and sputum as well as inflammatory process that lead to 
the obstructive disease.  This study has successfully used the AgNOR method to analyse oxygenic stress in 
COPD patients and smokers. The results show that heavy smokers and COPD patients have high levels of 
cellular proliferative activities in the oral mucosal epithelial cells, which reflects the level of hyperplasia 
existing in COPD patients. Tobacco smoking is responsible for the changes in the nuclear diameter and genetic 
structure. There was a strong association between AgNOR counts and histological changes in the oral mucosal 
cells and it can be used as a marker for the proliferative activity in the oral epithelial cells.  
The results showed that the oral cells are highly susceptible to cigarette smoking and this was indicated by an 
increase in the AgNOR counts inside the nucleus, which resulted from the increase of the proliferative activity. 
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